Igyxos
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Centre Inra Val De Loire Site De Tours, ...Phone Number
+33 247427957Website
www.igyxos.comRevenue
$5 MillionIndustry
About Igyxos
Igyxos Org Chart
Is Igyxos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Igyxos, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Igyxos recently announced quarterly report
Click to see if Igyxos had a recent Job posting/layoffs
Check out if Igyxos is spiking on competitors!
Product Launch: Get notified when Igyxos launches new products
Check if Igyxos has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Igyxos
Funding: Get notified immidiatlly once Igyxos has new funding data
Recommended Actions
Reach out to Masked Content who joined Igyxos as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Igyxos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Igyxos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Igyxos.
Igyxos Tech Stack
A closer look at the technologies used by Igyxos
Igyxos News & Media
Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility
TOURS, France, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced that it has secured a EUR 5.7 million grant under the France 2030 programme, via the “Biotherapies and Bioproduction of Innovative Therapies” call for projects (AAP), operated by Bpifrance on behalf of the French Government.Studies Suggest Sperm Counts Have Declined 50% in the Last 50 Years; New Innovation May Help Address Male Infertility
NOUZILLY, FRANCE, June 4, 2024 /EINPresswire.com/ -- A 2022 review found that human sperm counts in adult males have steadily declined, decreasing an average of 1.2% per year globally since 1973 and falling from 104 million to 49 million per milliliter …Igyxos Announces Successful Closure of Second Largest Investment Round in its History, Marking a Milestone in its Growth
Financial proceeds will be used to advance Igyxos infertility breakthrough treatment towards its goal to transform lives of many facing fertility problems PARIS, FRANCE, November 14, 2023 /EINPresswire.com/ -- Igyxos Announces Successful Closure of Its …Igyxos Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility
IGX12 is a pioneering monoclonal antibody (mAb) with very strong and consistent pre-clinical results and the potential to revolutionize infertility treatment PARIS, FRANCE, November 3, 2023 /EINPresswire.com/ -- Igyxos, a leading biopharmaceutical …
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Igyxos
Founded in 2017 and headquartered in Nouzilly, France, Igyxos, is dedicated to addressing the growing global need for improved infertility solutions through novel therapeutics that make treatment more effective and efficient for men and women.... Read More